As of May 27
| +0.0009 / +0.25%|
The 1 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 0.65, with a high estimate of 0.65 and a low estimate of 0.65. The median estimate represents a +79.81% increase from the last price of 0.36.
The current consensus among 1 polled investment analysts is to Hold stock in Synta Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.